Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABR hearing test in children with speech delay: inhalational versus intravenous anesthesia
RBR-5cgpv4tNot yet recruiting
- Sponsor
- Universidade de São Paulo
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sevoflurane and propofol in specific language impairment (DLD), sponsored by Universidade de São Paulo. Primary endpoints: Latency of wave I, Latency of wave III and 2 more. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
sevofluranepropofol
03
Conditions
specific language impairment (DLD)
Beyond the preview
Go deeper on RBR-5cgpv4t.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5cgpv4t.